Form 10-KT - Transition reports [Rule 13a-10 or 15d-10]:
SEC Accession No. 0001185185-26-000941
Filing Date
2026-03-18
Accepted
2026-03-18 16:02:27
Documents
97
Period of Report
2025-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-KT igc10kt123125.htm   iXBRL 10-KT 1326977
2 EXHIBIT 21.1 igcex21-1.htm EX-21.1 11365
3 EXHIBIT 23-1 igcex23-1.htm EX-23.1 2846
4 EXHIBIT 31.1 igcex31-1.htm EX-31.1 10570
5 EXHIBIT 31.2 igcex31-2.htm EX-31.2 10707
6 EXHIBIT 32.1 igcex32-1.htm EX-32.1 4080
7 EXHIBIT 32.2 igcex32-2.htm EX-32.2 3569
8 GRAPHIC image_001.jpg GRAPHIC 5219
  Complete submission text file 0001185185-26-000941.txt   6825892

Data Files

Seq Description Document Type Size
9 XBRL SCHEMA FILE igc-20251231.xsd EX-101.SCH 62629
10 XBRL CALCULATION FILE igc-20251231_cal.xml EX-101.CAL 44209
11 XBRL DEFINITION FILE igc-20251231_def.xml EX-101.DEF 273869
12 XBRL LABEL FILE igc-20251231_lab.xml EX-101.LAB 533269
13 XBRL PRESENTATION FILE igc-20251231_pre.xml EX-101.PRE 308224
101 EXTRACTED XBRL INSTANCE DOCUMENT igc10kt123125_htm.xml XML 752540
Mailing Address 10224 FALLS ROAD POTOMAC MD 20854
Business Address 10224 FALLS ROAD POTOMAC MD 20854 301-529-4996
IGC Pharma, Inc. (Filer) CIK: 0001326205 (see all company filings)

EIN.: 202760393 | State of Incorp.: MD | Fiscal Year End: 1231
Type: 10-KT | Act: 34 | File No.: 001-32830 | Film No.: 26768749
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)